Articles


Spectrum Pharmaceuticals Licenses Belinostat, A Novel Anticancer Drug In A Pivotal Registrational Trial

February 2, 2010

You can view this news at http://www.businesswire.com/news/home/20100202005914/en.

 

 

 

Most Popular

Need Information?

Please wait... busy